Rebecca Theresa Harper was born January 24, 1951 in Atchison, KS to Victor Edmond and Pauline Mary (Maday) Kesse and after a long and faith-filled fight with cancer, died March 14, 2016 in Kansas [...]
The Life Raft Group GIST Collaborative Tissue Bank consists of a collection of tumor specimens from a large number of patients, stored at Stanford University. The advantages of having a tissue bank for a [...]
Dear LRG Community, Thanks to our: Caregivers, the unsung heroes who care for and give to our patients every day Research team, who tirelessly reach for our mission to find a cure Donors, who [...]
It has been a long journey since that day Melinda and I walked out of my Dallas oncologist’s office in May, 2000 knowing that I had a rare, then untreatable cancer. Now, it has [...]
International support for the GIST Patient Community continues to grow. In this article, Amy Bruno-Lindner reports on GIST Support Austria. Since the summer of 2013, GIST patients in Austria have had someone to turn [...]
I had a “surprise” diagnosis of GIST in April, 2009, and thanks to the Life Raft Group and its knowledge and an excellent surgeon along with the assistance of Gleevec for about five years, [...]
The GIST Group Switzerland recently awarded its Science Prize to Dr. Anette Duensing, Assistant Professor of Pathology at the University of Pittsburgh Cancer Institute, and a member of the LRG’s Research Team. GIST Group [...]
Jayne Bressington, Patient Director of the PAWS-GIST Initiative & Trustee of GIST Support UK The first national Pediatric, Adolescent, Wild-type and Syndromic GIST (PAWS GIST) clinic in the United Kingdom was held on [...]
In a recently published article in Nature Genetics, several prominent cancer researchers and GIST experts, led by Dr. Dr. Yuexiang Wang and including Dr. Jonathan Fletcher of Brigham & Women’s Hospital and Dr. Matthew van de Rijn of Stanford University Center, who are both members of the LRG’s research team, discuss new research findings that may potentially help identify GIST patients with a future high risk for metastases.
The 2014 Zurich Declaration Principles for the transition to “Generic Drugs” for GIST (Gastrointestinal Stromal Tumors) Background and Purpose: GIST (Gastrointestinal Stromal Tumor) is a rare sarcoma, with an annual incidence of about 15 persons [...]
